GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Lipoprotein lipase (LPL), identified in the 1950s, has been studied intensively by biochemists, physiologists, and clinical investigators. These efforts uncovered a central role for LPL in plasma triglyceride metabolism and identified LPL mutations as a cause of hypertriglyceridemia. By the 1990s, with an outline for plasma triglyceride metabolism established, interest in triglyceride metabolism waned. In recent years, however, interest in plasma triglyceride metabolism has awakened, in part because of the discovery of new molecules governing triglyceride metabolism. One such protein—and the focus of this review—is GP IHBP1, a protein of capillary endothelial cells. GPIHBP1 is LPL’s essential partner: it binds LPL and transports it to the capillary lumen; it is essential for lipoprotein margination along capillaries, allowing lipolysis to proceed; and it preserves LPL’s structure and activity. Recently, GPIHBP1 was the key to solving the structure of LPL. These developments have transformed the models for intravascular triglyceride metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular atlas of cell types and zonation in the brain vasculature
Vanlandewijck, M., He, L., Mäe, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Nature · doi:10.1038/nature25739 · Cited by 1,892 · cited 1×
“Consistent with immunohistochemistry studies, Gpihbp1 transcripts are absent from capillary endothelial cells of the brain, as judged by single-cell RNA-seq studies (He et al., 2018b; Vanlandewijck et al., 2018).”
BackgroundSugar for the brain: the role of glucose in physiological and pathological brain function
Mergenthaler, P., Lindauer, U., Dienel, G. A., & Meisel, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.001 · Cited by 1,612 · cited 1×
“, 2010), which uses glucose for fuel (Mergenthaler et al., 2013).”
BackgroundExtreme disorder in an ultrahigh-affinity protein complex
Borgia, A., Borgia, M. B., Bugge, K., Kissling, V. M., Heidarsson, P. O., Fernandes, C. B., Sottini, A., Soranno, A., Buholzer, K. J., Nettels, D., et al. (2018) · Nature · doi:10.1038/nature25762 · Cited by 653 · cited 2×
“, 2016b), resulting in the formation of a “fuzzy complex” (Borgia et al., 2018; Ivic et al., 2019).”
BackgroundInactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497 · cited 1×
“The ANGPTL4E40K variant, present in 3% of Caucasians, is associated with lower plasma triglyceride levels and reduced risk of coronary disease (Dewey et al., 2016; Helgadottir et al., 2016; Investigators et al., 2016).”
BackgroundCoding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507652 · Cited by 493
Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types
He, L., Vanlandewijck, M., Mäe, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.160 · Cited by 413
Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation
Rip, J., Nierman, M. C., Ross, C. J., Jukema, J. W., Hayden, M. R., Kastelein, J. J. P., Stroes, E. S. G., & Kuivenhoven, J. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000219283.10832.43 · Cited by 157
Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.
Olivecrona, G., Ehrenborg, E., Semb, H., Makoveichuk, E., Lindberg, A., Hayden, M. R., Gin, P., Davies, B. S. J., Weinstein, M. M., Fong, L. G., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002717 · Cited by 118 · cited 3×
“Soon after the discovery of chylomicronemia in Gpihbp1–/– mice, GPIHBP1 mutations were identified in patients with familial chylomicronemia syndrome (Ariza et al., 2016; Beigneux et al., 2009a; Charriere et al., 2011; Coca-Prieto et al., 2011; Franssen et al., 2010; GonzagaJauregui et al., 2014; Olivecrona et al., 201…”
BackgroundSelf-citationAngiopoietin-like Protein 4 Inhibition of Lipoprotein Lipase
Lafferty, M. J., Bradford, K. C., Erie, D. A., & Neher, S. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497602 · Cited by 88 · cited 1×
“ANGPTL4 is reversible when the inactivation of LPL is performed in the presence of deoxycholate (Gutgsell et al., 2019; Lafferty et al., 2013), a detergent that stabilizes LPL activity (Bengtsson and Olivecrona, 1979).”
BackgroundThe acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.
Gin, P., Yin, L., Davies, B. S. J., Weinstein, M. M., Ryan, R. O., Bensadoun, A., Fong, L. G., Young, S. G., & Beigneux, A. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802579200 · Cited by 85 · cited 2×
“Our best guess is that the HDL used in the initial screen contained small amounts of LPL (which binds to GPIHBP1 avidly) or was enriched in apo-AV (a “heparin-binding” apolipoprotein that has been reported to bind to the negatively charged domain at the amino terminus of GPIHBP1) (Gin et al., 2011; Gin et al., 2008).”
BackgroundSelf-citationChylomicronemia elicits atherosclerosis in mice—brief report.
Weinstein, M. M., Yin, L., Tu, Y., Wang, X., Wu, X., Castellani, L. W., Walzem, R. L., Lusis, A. J., Fong, L. G., Beigneux, A. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196329 · Cited by 71 · cited 1×
“The first clue that GPIHBP1 was important for plasma triglyceride metabolism was finding severe hypertriglyceridemia in Gpihbp1 knockout mice (Gpihbp1–/–) (Beigneux et al., 2007; Weinstein et al., 2010a; Weinstein et al., 2010b).”
Self-citationExtreme hypertriglyceridemia: genetic diversity, pancreatitis, pregnancy, and prevalence
Chyzhyk, V., Kozmic, S., Brown, A. S., Hudgins, L. C., Starc, T. J., Davila, A. D., Blevins, T. C., Diffenderfer, M. R., He, L., Geller, A. S., et al. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.09.007 · Cited by 44 · cited 1×
“A G175R substitution has been observed in several patients with hypertriglyceridemia (Beigneux et al., 2017; Charriere et al., 2011; Chyzhyk et al., 2019) but is unlikely to be causative.”
Background
Cited by
A Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Biosynthesis and biology of mammalian GPI-anchored proteins
Kinoshita, T. (2020) · Open Biology · doi:10.1098/rsob.190290 · Cited by 341
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315
Lipoprotein lipase and its regulators: an unfolding story
Wu, S. A., Kersten, S., & Qi, L. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.11.005 · Cited by 225
Lipid and Lipoprotein Metabolism
Feingold, K. R. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.008 · Cited by 197
Metadata
- Authors
- Young, S. G., Fong, L. G., Beigneux, A. P., Allan, C. M., He, C., Jiang, H., Nakajima, K., Meiyappan, M., Birrane, G., & Ploug, M.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 30
- Issue
- 1
- Pages
- 51-65
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2956054395
- Cited by
- 141
- References
- 12
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.